Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy

• Status: Active, not recruiting
• Trial end date: 2021-01-01
• Target enrollment: 0
• Participant gender: All

Summary

In a brief summary the study would like to evaluate the effectiveness of Naproxen in preventing radiographically detected heterotopic ossification following hip arthroscopy for the treatment of femoroacetabular impingement.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Utah
• Treatments: Naproxen; Polystyrene sulfonic acid

Criteria

Inclusion Criteria:

• The patient is 18-80 years of age.

• The patient has provided written informed consent.

• The patient is scheduled for hip arthroscopy surgery for treatment of FAI

• The patient has an ASA of I, II, or III.

• The patients understands the explanation of the protocol.

Exclusion Criteria:

• The patient has history of a major GI bleeding event

• The patients has a history of renal impairment or creatinine > 1.5

• The patient has taken NSAIDs within 48 hours of surgery or in the perioperative period

• The patient has a history of heterotopic ossification following surgery

• The patient has a hypersensitivity reaction to Naproxen

• The patient is undergoing a concomitant procedure in addition to treatment of FAI